stockmarketproxy
/
BIIBNasdaq SEC EDGAR

BIOGEN INC.

Biological Products, (No Diagnostic Substances)·CAMBRIDGE, MA·FY end 12/31·CIK 875045
OverviewFinancialsCompensationGovernanceInsidersFilings

Named Executive Officers

FY 2025
ExecutiveSalaryStockOptionsBonus / Inc.OtherTotal
Christopher A. ViehbacherPresident and Chief Executive Officer
$1.7M$18.4M$3.2M$358.4K$23.6M
Susan H. AlexanderExecutive Vice President, Chief Legal Officer
$1.0M$5.8M$1.1M$197.1K$8.1M
Nicole C. Murphy Headof Pharmaceutical Operations and Technology
$909.1K$5.6M$977.8K$122.5K$7.6M
Priya A. Singhal Headof Development
$929.7K$5.6M$951.7K$123.9K$7.6M

CEO pay mix

Christopher A. Viehbacher · FY 2025
Total$23.6M
Stock awards$18.4M78%
Performance bonus$3.2M13%
Salary$1.7M7%
Other$358.4K2%

Performance vs. pay

TSR % vs. CEO comp actually paid · 6 fiscal years · Item 402(v) disclosure
FY
TSR
CEO comp
FY20
-17%
$9M
FY21
-2%
$15M
FY22
+13%
$28M
FY23
+6%
$-4M
FY24
-38%
$1M
FY25
-28%
$28M

CEO comp · median worker · ratio — 2-year trend

CEO total compMedian employeePay ratio (right axis)
$27M145$20M109$13M73$7M36$0M0FY24FY25